跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Gilead Sciences Ireland Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 21, 2021
Approval ID
77b7dbe0d6fd679a
Company
Gilead Sciences Ireland Unlimited Company
Type
Standard
Approval Details
Approval Id
77b7dbe0d6fd679a
Drug Cima Aemps Name
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1151061001IP
Holder Company Name
Gilead Sciences Ireland Unlimited Company
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Authorization Date
2021-06-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150/150/200/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Gilead Sciences Ireland Unlimited Company
Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
GILEAD SCIENCES IRELAND UNLIMITED COMPANY
Country Name
Ireland
City Name
carrigtwohill,country_ie
Address
Ida Business & Technology Park
Active Ingredients
EMTRICITABINA
200 mg
TENOFOVIR ALAFENAMIDA
10 mg
ELVITEGRAVIR
150 mg
COBICISTAT
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 21, 2021
Approval ID
77b7dbe0d6fd679a
Type
Standard
Back to CIMA-AEMPS Approvals